These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


240 related items for PubMed ID: 8272051

  • 1. [Intrahepatic cholangiocarcinoma: proposal of new macroscopic classification].
    Yamamoto J, Kosuge T, Shimada K, Takayama T, Yamasaki S, Ozaki H, Makuuchi M.
    Nihon Geka Gakkai Zasshi; 1993 Nov; 94(11):1194-200. PubMed ID: 8272051
    [Abstract] [Full Text] [Related]

  • 2. Intrahepatic peripheral cholangiocarcinoma: mode of spread and choice of surgical treatment.
    Sasaki A, Aramaki M, Kawano K, Morii Y, Nakashima K, Yoshida T, Kitano S.
    Br J Surg; 1998 Sep; 85(9):1206-9. PubMed ID: 9752860
    [Abstract] [Full Text] [Related]

  • 3. Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival.
    Ohtsuka M, Ito H, Kimura F, Shimizu H, Togawa A, Yoshidome H, Miyazaki M.
    Br J Surg; 2002 Dec; 89(12):1525-31. PubMed ID: 12445060
    [Abstract] [Full Text] [Related]

  • 4. Surgical treatment of intrahepatic cholangiocarcinoma: four patients surviving more than five years.
    Yamamoto J, Kosuge T, Takayama T, Shimada K, Makuuchi M, Yoshida J, Sakamoto M, Hirohashi S, Yamasaki S, Hasegawa H.
    Surgery; 1992 Jun; 111(6):617-22. PubMed ID: 1317612
    [Abstract] [Full Text] [Related]

  • 5. Intrahepatic cholangiocarcinoma: macroscopic type and stage classification.
    Yamasaki S.
    J Hepatobiliary Pancreat Surg; 2003 Jun; 10(4):288-91. PubMed ID: 14598147
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Clinicopathological characteristics of intrahepatic cholangiocellular carcinoma presenting intrahepatic bile duct growth.
    Yamamoto Y, Shimada K, Sakamoto Y, Esaki M, Nara S, Ban D, Kosuge T, Ojima H.
    J Surg Oncol; 2009 Mar 01; 99(3):161-5. PubMed ID: 19101954
    [Abstract] [Full Text] [Related]

  • 11. Histologic bile duct invasion by a mass-forming intrahepatic cholangiocarcinoma.
    Hirohashi K, Uenishi T, Kubo S, Yamamoto T, Tanaka H, Shuto T, Yamasaki O, Horii K, Kinoshita H.
    J Hepatobiliary Pancreat Surg; 2002 Mar 01; 9(2):233-6. PubMed ID: 12140612
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Clinicopathologic features in patients with long-term survival following resection for intrahepatic cholangiocarcinoma.
    Uenishi T, Hirohashi K, Kubo S, Yamamoto T, Yamazaki O, Shuto T, Tanaka H, Kinoshita H.
    Hepatogastroenterology; 2003 Mar 01; 50(52):1069-72. PubMed ID: 12845984
    [Abstract] [Full Text] [Related]

  • 14. Influence of hepatic resection margin on recurrence and survival in intrahepatic cholangiocarcinoma.
    Tamandl D, Herberger B, Gruenberger B, Puhalla H, Klinger M, Gruenberger T.
    Ann Surg Oncol; 2008 Oct 01; 15(10):2787-94. PubMed ID: 18685896
    [Abstract] [Full Text] [Related]

  • 15. Hepatopancreatoduodenectomy could be allowed for patients with advanced intrahepatic cholangiocarcinoma.
    Urahashi T, Yamamoto M, Ohtsubo T, Katsuragawa H, Katagiri S, Takasaki K.
    Hepatogastroenterology; 2007 Mar 01; 54(74):346-9. PubMed ID: 17523271
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Hepatic resection for intrahepatic cholangiocarcinoma: relation to gross tumor morphology.
    Itamoto T, Asahara T, Katayama K, Nakahara H, Fukuda T, Yano M, Hino H, Nakahara M, Dohi K, Shimamoto F.
    Hepatogastroenterology; 2001 Mar 01; 48(40):1129-33. PubMed ID: 11490816
    [Abstract] [Full Text] [Related]

  • 18. Clinicopathological prognostic factors after hepatectomy for patients with mass-forming type intrahepatic cholangiocarcinoma: relevance of the lymphatic invasion index.
    Shirabe K, Mano Y, Taketomi A, Soejima Y, Uchiyama H, Aishima S, Kayashima H, Ninomiya M, Maehara Y.
    Ann Surg Oncol; 2010 Jul 01; 17(7):1816-22. PubMed ID: 20135355
    [Abstract] [Full Text] [Related]

  • 19. An intraductal papillary component is associated with prolonged survival after hepatic resection for intrahepatic cholangiocarcinoma.
    Tajima Y, Kuroki T, Fukuda K, Tsuneoka N, Furui J, Kanematsu T.
    Br J Surg; 2004 Jan 01; 91(1):99-104. PubMed ID: 14716802
    [Abstract] [Full Text] [Related]

  • 20. Surgery for periductal infiltrating type intrahepatic cholangiocarcinoma without hilar invasion provides a better outcome than for mass-forming type intrahepatic cholangiocarcinoma without hilar invasion.
    Imai K, Yamamoto M, Ariizumi S.
    Hepatogastroenterology; 2010 Jan 01; 57(104):1333-6. PubMed ID: 21443080
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.